226 related articles for article (PubMed ID: 31229264)
1. Future directions in soft tissue sarcoma treatment.
Hall F; Villalobos V; Wilky B
Curr Probl Cancer; 2019 Aug; 43(4):300-307. PubMed ID: 31229264
[TBL] [Abstract][Full Text] [Related]
2. Emerging Targeted and Immune-Based Therapies in Sarcoma.
Pollack SM; Ingham M; Spraker MB; Schwartz GK
J Clin Oncol; 2018 Jan; 36(2):125-135. PubMed ID: 29220291
[TBL] [Abstract][Full Text] [Related]
3. Next frontiers in systemic therapy for soft tissue sarcoma.
Yen CC; Chen TW
Chin Clin Oncol; 2018 Aug; 7(4):43. PubMed ID: 30173533
[TBL] [Abstract][Full Text] [Related]
4. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.
Tsuji K; Ishikawa Y; Imamura T
Hum Pathol; 2012 Mar; 43(3):356-63. PubMed ID: 21835426
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in soft-tissue sarcoma.
Ayodele O; Razak ARA
Curr Oncol; 2020 Feb; 27(Suppl 1):17-23. PubMed ID: 32174754
[TBL] [Abstract][Full Text] [Related]
6. Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients.
Gan M; Zhang C; Qiu L; Wang Y; Bao H; Yu R; Liu R; Wu X; Shao Y; Hou P; Fei Z
Cancer Med; 2022 Nov; 11(21):4070-4078. PubMed ID: 35586877
[TBL] [Abstract][Full Text] [Related]
7. More Than 50 Subtypes of Soft Tissue Sarcoma: Paving the Path for Histology-Driven Treatments.
Katz D; Palmerini E; Pollack SM
Am Soc Clin Oncol Educ Book; 2018 May; 38():925-938. PubMed ID: 30231352
[TBL] [Abstract][Full Text] [Related]
8. Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma.
Wisdom AJ; Mowery YM; Riedel RF; Kirsch DG
Cancer; 2018 Oct; 124(19):3819-3829. PubMed ID: 29723407
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Management of Retroperitoneal Soft Tissue Sarcomas.
Olimpiadi Y; Song S; Hu JS; Matcuk GR; Chopra S; Eisenberg BL; Sener SF; Tseng WW
Curr Oncol Rep; 2015 Aug; 17(8):39. PubMed ID: 26092408
[TBL] [Abstract][Full Text] [Related]
10. Soft tissue sarcoma: from molecular diagnosis to selection of treatment. Pathological diagnosis of soft tissue sarcoma amid molecular biology and targeted therapies.
Wardelmann E; Schildhaus HU; Merkelbach-Bruse S; Hartmann W; Reichardt P; Hohenberger P; Büttner R
Ann Oncol; 2010 Oct; 21 Suppl 7():vii265-9. PubMed ID: 20943625
[TBL] [Abstract][Full Text] [Related]
11. Making progress in a rare disease: emerging therapeutics in soft tissue sarcomas.
Choe J; Riedel R
F1000Res; 2018; 7():. PubMed ID: 30450193
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
Nathenson MJ; Conley AP; Sausville E
Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
[TBL] [Abstract][Full Text] [Related]
13. Contemporary management of metastatic soft tissue sarcoma.
Bui NQ; Wang DS; Hiniker SM
Curr Probl Cancer; 2019 Aug; 43(4):289-299. PubMed ID: 31248634
[TBL] [Abstract][Full Text] [Related]
14. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
15. Potential for immunotherapy in soft tissue sarcoma.
Tseng WW; Somaiah N; Engleman EG
Hum Vaccin Immunother; 2014; 10(11):3117-24. PubMed ID: 25625925
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of sarcomas.
Goldberg JM
Curr Opin Oncol; 2013 Jul; 25(4):390-7. PubMed ID: 23736878
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies.
Linch M; Miah AB; Thway K; Judson IR; Benson C
Nat Rev Clin Oncol; 2014 Apr; 11(4):187-202. PubMed ID: 24642677
[TBL] [Abstract][Full Text] [Related]
18. First-Line Therapy for Metastatic Soft Tissue Sarcoma.
Meyer M; Seetharam M
Curr Treat Options Oncol; 2019 Jan; 20(1):6. PubMed ID: 30675651
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic considerations: how can we fine tune our approach to sarcoma?
Demicco EG; Lazar AJ
Semin Oncol; 2011 Oct; 38 Suppl 3():S3-18. PubMed ID: 22055969
[TBL] [Abstract][Full Text] [Related]
20. Combined modality treatment of extremity soft tissue sarcomas.
Pisters PW
Ann Surg Oncol; 1998; 5(5):464-72. PubMed ID: 9718178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
